Increased hepatic and decreased urinary metallothionein in rats after cessation of oral cadmium exposure.
We investigated the role of metallothionein (MT) in tissues after cessation of cadmium (Cd) exposure. Wistar rats of both genders were given CdCl(2) in drinking water at daily doses of 0, 2.5, 5.0 or 10.0 mg Cd/kg body-weight for 12 weeks. Half of the animals were then killed; the others were given Cd-free water for the following 16 weeks, i.e. until 28 weeks after start of the experiment (28-week rats). We observed dose-dependent increases in the levels of MT in the tissues of rats 12 weeks after beginning the experiment (12-week rats). After the exposure ceased, levels of MT in the 28-week rats changed in three ways: an increase in the liver, persistence in the kidney cortex and a decrease in the medulla, relative to those levels in their 12-week counterparts. Biomarkers of kidney dysfunction were determined to be urinary MT (UMT) and urinary N-acetyl-beta-D-glucosaminidase (UNAG). After 12 weeks, we observed dose-related statistically significant increases in UMT and UNAG in all of the Cd-exposed groups. A statistically significant decrease for UNAG between the 12- and 28-week rats occurred among males at the lowest Cd dose and for UMT in all of the Cd-exposed groups. The unchanged tissue levels of MT in the kidney cortex suggest that decreased UMT is a sign either of (i) decreased transport of Cd-MT from the liver via blood plasma to the renal tubules or (ii) increased tubular reabsorption and recovery of renal tubular function.
Liang
Yihuai
Y
Department of Occupational Health and Toxicology, School of Public Health, Fudan University, Shanghai, China.
Li
Huiqi
H
Xiang
Cuiqin
C
Lei
Lijian
L
Jin
Taiyi
T
Nordberg
Monica
M
Nordberg
Gunnar F
GF
D000118:Acetylglucosaminidase / Q000652:urine; D000284:Administration, Oral; D000818:Animals; D001692:Biological Transport; D015415:Biomarkers / Q000378:metabolism; D019256:Cadmium Chloride / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism; D007679:Kidney Medulla / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008668:Metallothionein / Q000378:metabolism* / Q000652:urine; D051381:Rats; D017208:Rats, Wistar; D012737:Sex Factors; D013997:Time Factors
D015415:Biomarkers; D008668:Metallothionein; D000118:Acetylglucosaminidase; D019256:Cadmium Chloride